Pharmafile Logo
Pharmafocus logo
Advanced Search

Witty hits out at ‘systematic delays’ to medicines

February 27, 2012
Sales and Marketing Europe, GSK, NICE, austerity

 GlaxoSmithKline’s chief executive says Europe’s drug budget cuts are undermining the industry and not addressing the biggest cost pressure in …

News

Janssen launches hep C support programme

February 27, 2012
Medical Communications, Sales and Marketing BUPA, Copegas, Incivo, Janssen, Pegasys, hep C

Janssen has launched a hepatitis C support programme for patients in the UK to help with medicine adherence and healthy …

News

On-going Medicine evaluation Information to be published by European Medicines Agency

February 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), …

News
Press release

EMA accepts Genzyme MS drug for review

February 24, 2012
Research and Development, Sales and Marketing EMA, Genzyme, Sanofi, teriflunomide

The European Medicines Agency has accepted Genzyme’s application for its multiple sclerosis pill teriflunomide.  Genzyme, which is wholly owned by …

News
werner_wenning_bayer

Werner Wenning proposed as chairman of the supervisory board at Bayer

February 24, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Schneider, Wenning

Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October. …

Appointment

Care regulator chief steps down

February 24, 2012
Sales and Marketing CQC, Cynthia Bower, Mid Staffs, reforms

The head of the Care Quality Commission Cynthia Bower has resigned from her post, amid growing pressure from the government. …

News
Genzyme picture

Genzyme to close UK site

February 24, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts

Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs.  …

News

The NHS, a postcard from the frontline

February 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brighton, NHS, Sussex, reforms

It is January 2012, and the NHS in England is under huge strain. This is because it is being asked …

Feature

Astellas hires senior vice president for new Global Medical Affairs organisation

February 24, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing

Astellas has announced that Charlotte Kremer has joined the company as the head of one of the Company’s newest organisations …

Appointment
European flag

Changes to patient information in Europe

February 23, 2012
Medical Communications, Sales and Marketing Commission, EC, ED, parliament

European authorities have made new proposals to allow pharma to communicate with patients and the public  – but a ban …

News
zoe_sycamore_p_forbes

Packer Forbes boosts team with two recruits

February 23, 2012
Medical Communications Packer Forbes

Specialist healthcare consultancy Packer Forbes Communications has announced two new appointments.  Two graduate recruits have been brought on board to …

Appointment
FDA picture

Obesity drug supported by FDA panel

February 23, 2012
Sales and Marketing FDA, Qnexa, Vivus, Xenical, obesity

Vivus’ obesity drug Qnexa has been supported by an FDA panel, two years after it was knocked back by the …

News
Lansley picture

GPs to ‘prescribe’ apps for patients

February 22, 2012
Medical Communications GPs, Lansley, NHS, apps

Family doctors in England could soon be asked to ‘prescribe’ apps to patients to help them manage their medical conditions. …

News
EMA image

EMA to open up drug evaluation process

February 22, 2012
Medical Communications, Sales and Marketing CHMP, EMA, FDA

The European Medicines Agency will publish ongoing drug evaluations in an effort to make its processes more transparent. The Agency …

News

CCGs already helping patients, says Lansley

February 22, 2012
CCGs, Lansley, NHS, NHS reform

The government has set out a number of ways in which its controversial health reforms are already benefiting patients. The …

News

Alex Gorsky named new chief executive of J&J

February 22, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Janssen, Weldon

Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated …

Appointment
Takeda image

Takeda’s ulcerative colitis drug gets Phase III boost

February 22, 2012
Research and Development

Takeda’s ulcerative colitis drug vedolizumab has succeeded in a late-stage trial.  The Phase III trial studied vedolizumab in 895 patients …

News

Publicis buys Chinese med comms firm

February 22, 2012
Medical Communications Publicis Life Brands Watermelon, UBS, publicis

Publicis has acquired Chinese healthcare communications firm U-Link Business Solutions (UBS), adding to its portfolio in Asia.UBS will become part …

News
Caprelsa image

Caprelsa approved in Europe for thyroid cancer

February 21, 2012
Sales and Marketing AstraZeneca, Caprelsa, FDA, RET, thyroid cancer

The European Commission has approved AstraZeneca’s thyroid cancer pill Caprelsa. Caprelsa (vandetanib) is now available in Europe for the treatment …

News
Zytiga image

Zytiga approved in Wales – for now

February 21, 2012
Sales and Marketing AWMSG, CDF, Janssen, NICE, Wales, Zytiga

Janssen’s cancer treatment Zytiga has been approved in Wales, in contrast to its rejection by NICE. The All Wales Medicines …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026